5G mobile cellular networks are required to provide the significant increase in network throughput, cell-edge data rate, massive connectivity, superior spectrum efficiency, high energy efficiency and low latency, comp...5G mobile cellular networks are required to provide the significant increase in network throughput, cell-edge data rate, massive connectivity, superior spectrum efficiency, high energy efficiency and low latency, compared with the currently deploying long-term evolution （LTE） and LTE-advanced networks. To meet these challenges of 5G networks, innovative technologies on radio air-interface and radio access network （RAN） are important in PHY design. Recently,展开更多
5G mobile cellular networks are required to provide the significant increase in network throughput,cell-edge data rate,massive connectivity,superior spectrum efficiency,currently deploying long-term evolution(LTE)and ...5G mobile cellular networks are required to provide the significant increase in network throughput,cell-edge data rate,massive connectivity,superior spectrum efficiency,currently deploying long-term evolution(LTE)and LTE-advanced networks.To meet these challenges of 5G networks,展开更多
Objective To study the content of China’s guiding principles on multiplicity issues in clinical trials,and to provide reference for the revision of China’s relevant guiding principles.Methods Based on ICH E9,the sim...Objective To study the content of China’s guiding principles on multiplicity issues in clinical trials,and to provide reference for the revision of China’s relevant guiding principles.Methods Based on ICH E9,the similarities and differences of the guiding principles of US Food and Drug Administration(FDA),European Medicines Agency(EMA),and National Medical Products Administration(NMPA)on the multiplicity issues in clinical trials were compared one by one.Results and Conclusion In general,NMPA guidelines are based on ICH E9,but in detail,the guidelines of FDA and EMA focus differently on the multiplicity issues.Therefore,NMPA guidelines need to be detailed and comprehensive.NMPA guidelines can be refined by referring to foreign guidelines to improve the practical guiding significance for clinical research and promote the level of domestic clinical trials in line with international standards.展开更多
文摘5G mobile cellular networks are required to provide the significant increase in network throughput, cell-edge data rate, massive connectivity, superior spectrum efficiency, high energy efficiency and low latency, compared with the currently deploying long-term evolution （LTE） and LTE-advanced networks. To meet these challenges of 5G networks, innovative technologies on radio air-interface and radio access network （RAN） are important in PHY design. Recently,
文摘5G mobile cellular networks are required to provide the significant increase in network throughput,cell-edge data rate,massive connectivity,superior spectrum efficiency,currently deploying long-term evolution(LTE)and LTE-advanced networks.To meet these challenges of 5G networks,
基金supported by the Special Foundation of Research Institute of Drug Regulatory Science,Shenyang Pharmaceutical University(2021jgkx004).
文摘Objective To study the content of China’s guiding principles on multiplicity issues in clinical trials,and to provide reference for the revision of China’s relevant guiding principles.Methods Based on ICH E9,the similarities and differences of the guiding principles of US Food and Drug Administration(FDA),European Medicines Agency(EMA),and National Medical Products Administration(NMPA)on the multiplicity issues in clinical trials were compared one by one.Results and Conclusion In general,NMPA guidelines are based on ICH E9,but in detail,the guidelines of FDA and EMA focus differently on the multiplicity issues.Therefore,NMPA guidelines need to be detailed and comprehensive.NMPA guidelines can be refined by referring to foreign guidelines to improve the practical guiding significance for clinical research and promote the level of domestic clinical trials in line with international standards.
